Jose L. Mauriz
Leon, CL, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
Impeding hypoxia-driven tumor progression in hepatocellular carcinoma: clinical and pre-clinical analyses using 2D and 3D in vitro models.
Journal: Biology direct
Published: February 23, 2026
Effects of Melatonin and Akkermansia muciniphila on the Gut-Liver Axis in a MASLD-Associated Liver Fibrosis Model: An Integrative Multi-Omic Approach.
Journal: Antioxidants (Basel, Switzerland)
Published: February 02, 2026
Strategies to enhance the response of liver cancer to pharmacological treatments.
Journal: American journal of physiology. Cell physiology
Published: May 06, 2024
Efficacy and safety of regorafenib as a first-line agent alone or in combination with an immune checkpoint inhibitor for advanced hepatocellular carcinoma: a retrospective cohort study.
Journal: Journal of gastrointestinal oncology
Published: April 29, 2024
Molecular characterization of autophagic and apoptotic signaling induced by sorafenib in liver cancer cells.
Journal: Journal of cellular physiology
Published: February 04, 2024
Risk versus Benefit of Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Journal: Clinical pharmacology and therapeutics
Published: November 07, 2023
Therapeutic approaches in intermediate-stage hepatocellular carcinoma (HCC): a novel insight of adjuvant transarterial chemoembolization (TACE).
Journal: Chinese clinical oncology
Published: March 08, 2023
Neuropilins as potential biomarkers in hepatocellular carcinoma: a systematic review of basic and clinical implications.
Journal: Clinical and molecular hepatology
Published: November 28, 2022
Anti-retinal Antibodies in Sarcoidosis.
Journal: Ocular immunology and inflammation
Published: October 14, 2022
Last Updated: 09/26/2026